Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

51.9K
Overview
51.9K
Cancer Vaccines01:30

Cancer Vaccines

1.1K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.1K
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

1.2K
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
1.2K
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

237
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
237
Types of RNA01:23

Types of RNA

73.2K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
73.2K
Types of Hormones02:13

Types of Hormones

84.6K
Hormones can be classified into three main types based on their chemical structures: steroids, peptides, and amines. Their actions are mediated by the specific receptors they bind to on target cells.
84.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incidence of Recurrent Respiratory Papillomatosis (RRP) in Denmark and Sweden During 2000-2023: Two Nationwide Cohort Studies in Children and Young Adults.

Open forum infectious diseases·2026
Same author

Racial Disparities and Personal Responsibility Incentives in Medicaid.

Health services research·2026
Same author

Incidence of human papillomavirus infections in women aged 27 years and older in the US: A federated data network study.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same author

Dengue Incidence, Seroprevalence, and Expansion Factors from Active Surveillance, Brazil, 2016-2021.

Emerging infectious diseases·2026
Same author

High Risk of Incident-Persistent Human Papillomavirus Infection With 9-Valent Vaccine Types in Young Men With an HPV Infection.

Open forum infectious diseases·2026
Same author

Etiologic heterogeneity across oral cavity cancers.

Cancer·2026
Same journal

Resolution Biology in Soft Tissue Joint Disease.

Current topics in microbiology and immunology·2026
Same journal

A 25+ Year Journey on Yeast-Regulated Cell Death Research.

Current topics in microbiology and immunology·2026
Same journal

Adoptive T-Cell Immunotherapy.

Current topics in microbiology and immunology·2026
Same journal

Resolution Pharmacology Targeting the Melanocortin System.

Current topics in microbiology and immunology·2026
Same journal

Resolution of Skeletal Muscle Inflammation: Role of Specialized Pro-resolving Lipid Mediators in the Recovery from Exercise, Injury, and Disease.

Current topics in microbiology and immunology·2026
Same journal

Epstein-Barr Virus: From the Detection of Sequence Polymorphisms to the Recognition of Viral Strains.

Current topics in microbiology and immunology·2026
See all related articles

Related Experiment Video

Updated: Feb 16, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.3K

HPV Type Replacement After HPV Vaccination.

Elizabeth M Anderson1, Alfred J Saah1, Joseph E Tota2

  • 1Merck & Co., Inc., Rahway, NJ, USA.

Current Topics in Microbiology and Immunology
|February 15, 2026
PubMed
Summary
This summary is machine-generated.

Human papillomavirus (HPV) vaccination prevents HPV-attributable cancers. Potential increases in nonvaccine HPV types may be due to clinical or viral unmasking, not type replacement.

Keywords:
Clinical unmaskingHPV vaccineHuman papillomavirusType replacementVaccine effectivenessViral unmasking

More Related Videos

Transient Expression in Red Beet of a Biopharmaceutical Candidate Vaccine for Type-1 Diabetes
10:16

Transient Expression in Red Beet of a Biopharmaceutical Candidate Vaccine for Type-1 Diabetes

Published on: March 19, 2019

8.4K
Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.8K

Related Experiment Videos

Last Updated: Feb 16, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.3K
Transient Expression in Red Beet of a Biopharmaceutical Candidate Vaccine for Type-1 Diabetes
10:16

Transient Expression in Red Beet of a Biopharmaceutical Candidate Vaccine for Type-1 Diabetes

Published on: March 19, 2019

8.4K
Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.8K

Area of Science:

  • Oncology
  • Virology
  • Public Health

Background:

  • Human papillomavirus (HPV) vaccination is highly effective in preventing HPV-attributable cancers.
  • Concerns exist regarding a potential increase in precancer prevalence from nonvaccine HPV types post-vaccination.
  • This phenomenon may challenge the perceived impact of HPV vaccination programs.

Purpose of the Study:

  • To explore potential explanations for the observed increase in nonvaccine HPV types in the post-vaccination era.
  • To differentiate between HPV type replacement, clinical unmasking, and viral unmasking as causes.
  • To elucidate the underlying mechanisms of these processes.

Main Methods:

  • Review of existing literature on HPV epidemiology and vaccine impact.
  • Analysis of proposed mechanisms: HPV type replacement, clinical unmasking, and viral unmasking.
  • Discussion of viral genetic stability and HPV coinfection dynamics.

Main Results:

  • HPV type replacement is considered unlikely due to viral genetic stability and lack of inter-type competition.
  • Clinical unmasking is plausible, as reduced intervention for vaccine types may allow nonvaccine types to progress.
  • Viral unmasking, an assay artifact, presents a possibility for erroneous findings of type replacement.

Conclusions:

  • The observed increase in nonvaccine HPV types is likely attributable to clinical or viral unmasking, rather than true type replacement.
  • Understanding these mechanisms is crucial for accurately assessing HPV vaccine effectiveness.
  • Further research is needed to confirm the dominant mechanism and its implications for cervical cancer prevention strategies.